Asset Details
Do you wish to reserve the book?
Comparison of Microneedle Fractional Radiofrequency Therapy with Intradermal Botulinum Toxin A Injection for Periorbital Rejuvenation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparison of Microneedle Fractional Radiofrequency Therapy with Intradermal Botulinum Toxin A Injection for Periorbital Rejuvenation
Do you wish to request the book?
Comparison of Microneedle Fractional Radiofrequency Therapy with Intradermal Botulinum Toxin A Injection for Periorbital Rejuvenation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comparison of Microneedle Fractional Radiofrequency Therapy with Intradermal Botulinum Toxin A Injection for Periorbital Rejuvenation
2013
Overview
Background: For periorbital rejuvenation, injection of botulinum toxin A (BoNT/A) is known to improve both static as well as dynamic wrinkles. A microneedle fractional radiofrequency (MFR) device was recently developed and is a novel and promising tool. Objective: This study compares the effects of these two treatment modalities on periorbital static wrinkles and lines. Methods: Twelve healthy women aged 20-59 years with periorbital wrinkles participated in this study. Each patient received one session of intradermal injection of BoNT/A on the left periorbital area and three sessions of MFR on the right. Clinical improvement, skin elasticity and subjective satisfaction were evaluated at every visit (baseline, 3, 6 and 18 weeks). Results: BoNT/A injection showed superior effects at 3 and 6 weeks. However, the MFR device showed better improvement at 18 weeks. In skin biopsies, the expression of procollagen 3 and elastin was increased on the MFR side compared to the untreated skin and the BoNT/A injection side. The patient satisfaction surveys at 3 weeks showed better satisfaction on the BoNT/A treatment side compared to the MFR treatment side. At 18 weeks, there were no significant differences in patient satisfaction between the two sides. Conclusion: BoNT/A injection rapidly improved periorbital wrinkles, but the effect decreased up to week 18. Compared to BoNT/A injection, MFR therapy showed gradual and long-term improvement in periorbital rejuvenation.
Publisher
S. Karger AG
Subject
/ Aging
/ Botulinum Toxins, Type A - adverse effects
/ Botulinum Toxins, Type A - therapeutic use
/ Catheter Ablation - adverse effects
/ Collagen Type III - analysis
/ Eye
/ Female
/ Humans
/ Needles
/ Neuromuscular Agents - adverse effects
/ Neuromuscular Agents - therapeutic use
